The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Congress has passed legislation giving the FDA new powers of oversight concerning the pharmaceutical industry including more authority to require changes to drug labels, demand additional safety studies and limit the distribution of medications when safety concerns arise. The new legislation includes an interesting twist in that it may limit protection of pharmaceutical companies for drugs that have the FDA stamp of approval. The Bush Administration sided with the drug companies a year ago when it successfully argued that FDA approval of a drug absolves them from legal liability. This new legislation calls this Bush pre-emption into question, a good thing for consumers.

For more information on this subject matter, please refer to the section on Drugs, Medical Devices, and Implants.

Comments are closed.

Of Interest